Recent Updates
Recently added Catalysts
RDY Positive Sentiment Score: 70/100

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN : L85195TG1984PLC004507 Tel : +91 40 4900 2900 Fax : +91 40 4900 2999 Email : mail@drreddys.com www.drreddys.co

Tuesday, October 29, 2024 1 min read
Key Takeaway: Dr. Reddy's Laboratories has announced a stock split, effective October 28, 2024, which will divide each equity share of Rs. 5 into five shares of Re. 1 each. The company's authorized capital will remain unchanged at Rs. 1,45,00,00,000, although the structure of issued and paid-up capital will be adjusted. This strategy aims to enhance share liquidity and attract more investors. Additionally, the move responds to market dynamics by making shares more affordable.

Market Sentiment Analysis

POSITIVE FACTORS

  • Dr. Reddy's Laboratories is enhancing its liquidity through a stock split.
  • The split will make shares more accessible to a broader range of investors.
  • The company's authorized capital will remain the same post-split.
  • This positive move could potentially attract more investments into the company.

Full Press Release Details

National Stock Exchange of India Ltd. (Stock Code:
BSE Limited (Stock Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
Sub: Update on Stock Split
In furtherance to our intimation dated October
04, 2024 regarding intimation of record date as October 28, 2024 for sub-division/ split of each equity share of Rs. 5/- (Rupees five
only) each, fully paid-up into 5 (five) equity shares of Re. 1/- (Rupee one only) each, fully paid-up, kindly note the Company's
authorized, issued and paid-up share capital as on October 28, 2024, pre and post sub-division as set out below:
Particulars Pre sub-division Post sub-division
Authorised Share Capital Rs. 1,45,00,00,000/- divided into 29,00,00,000 equity shares of Rs. 5/- each Rs. 1,45,00,00,000/- divided into 1,45,00,00,000 equity shares of Re. 1/- each
Issued Share Capital Rs. 83,43,85,730/- divided into 16,68,77,146 equity shares of Rs. 5/- each Rs. 83,43,85,730/- divided into 83,43,85,730 equity shares of Re. 1/- each
Paid-up Share Capital Rs. 83,43,84,730/- divided into 16,68,76,946 equity shares of Rs. 5/- each Rs. 83,43,84,730/- divided into 83,43,84,730 equity shares of Re. 1/- each
Note: The difference between issued and paid-up
capital is due to forfeiture of 200 shares of Rs.5/- each, pre sub-division, resulting in 1000 shares of Re.1/- each, post sub-division.
This is for your information and records.
For Dr. Reddy's Laboratories Limited
Company Secretary, Compliance Officer &

Frequently Asked Questions

What is the purpose of the stock split announcement?

The announcement details a stock split, subdividing each Rs. 5 share into five Rs. 1 shares.

When is the record date for the stock split?

The record date for the stock split is set for October 28, 2024.

What will happen to the authorized share capital post-split?

Post-split, the authorized share capital remains Rs. 1,45,00,00,000, now in Rs. 1 shares.

How does the issuance of shares change after the split?

Issued share capital will change from 16,68,77,146 shares to 83,43,85,730 shares post-split.

What caused the difference in paid-up and issued capital?

The difference is due to the forfeiture of 200 Rs. 5 shares before the split.

Tags: RDY Viatris Investor Conferences Healthcare Dr. Reddy's Laboratories stock split NSE share capital investments
Last updated: Oct 29, 2024